In the Original Investigation titled “Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database,”1 published September 10, 2021, there was an error in the Discussion. The third sentence of the first paragraph should have read, “First, nearly half of patients (47.58%) showed positivity for nonprescribed substances, particularly for marijuana, benzodiazepines, and gabapentin.” This article has been corrected.1
Error in Discussion. JAMA Netw Open. 2021;4(10):e2133270. doi:10.1001/jamanetworkopen.2021.33270
Customize your JAMA Network experience by selecting one or more topics from the list below.